JADE SIMON: Open Payments
NPI 1023470465 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,334 in 93 payments from 36 companies in 2025. Trend: 2023 $31 · 2024 $0 · 2025 $2,334
Food & beverage: $2,044Education: $290
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $223 |
| Exelixis Inc. | 4 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $164 |
| Gilead Sciences, Inc. | 3 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $144 |
| Merck Sharp & Dohme LLC | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 3 | $90 |
| PFIZER INC. | 5 | $88 |
| Incyte Corporation | 4 | $81 |
Products named: SARCLISA, ERLEADA, Trodelvy, KEYTRUDA, ENHERTU, ICLUSIG, Nubeqa, NINLARO.
Industry payments across TN — which companies pay providers there.
